MD

Megha Dilip Ambavale

Director Director DIN 03137711
DIN 03137711 First appointment Mar 2010 Primary industry Chemicals and Materials
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Megha Dilip Ambavale

Data last updated:

Megha Dilip Ambavale was a Director at Evershine Drug Product Private Limited (2010–2012) and Director at Evershine Pharmachem Limited (from 2010). The companies operate in Chemicals and Materials.

DIN 03137711
Primary Designation Director
Industry Chemicals and Materials
First Appointment 25 Mar 2010
Oldest Company Age 30 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Mar 20102009₹5.49 Cr (FY 2025)Active
Evershine Pharmachem Limited U24230MH1996PLC096644
Director07 Jul 20101996Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Evershine Pharmachem Limited
Evershine Drug Product Private Limited
Premium access

Shareholding and investment profile for Megha Dilip Ambavale

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Megha Dilip Ambavale

Megha Dilip Ambavale was first appointed on 25 Mar 2010 as Director at Evershine Drug Product Private Limited.

Megha Dilip Ambavale held 2 earlier board appointments: Evershine Drug Product Private Limited (Director, 25 Mar 2010 to 17 Dec 2012); Evershine Pharmachem Limited (Director, from 07 Jul 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available